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Background: The development of a nurse-led approach to managing epilepsy in adults 
with an intellectual disability offers the potential of improved outcomes and lower costs 
of care. We undertook a cluster randomised trial to assess the impact on costs and 
outcomes of the provision of intellectual disability nurses working to a designated 
epilepsy nurse competency framework. Here, we report the impact of the intervention 
on costs. 
Method: Across the UK, 8 sites randomly allocated to the intervention recruited 184 
participants, 9 sites allocated to treatment as usual recruited 128 participants. Cost and 
outcome data were collected mainly by telephone interview at baseline and after six 
months. Total costs at six months were compared from the perspective of health & 
social services, and society, with adjustments for pre-specified participant and cluster 
characteristics at baseline including costs. Missing data was imputed using Multiple 
Imputation. Uncertainty was quantified by bootstrapping.  
Results: The intervention was associated with lower per participant costs from a health 
& social services perspective of -£357 (2014/15 GBP) (95% CI -£986, £294) and from a 
societal perspective of -£631 (95% CI -£1,473, £181). Results were not sensitive to the 
exclusion of accommodation costs. 
Conclusions: Our findings suggest that the competency framework is unlikely to 
increase the cost of caring for people with epilepsy and intellectual disability and may 
reduce costs.  
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Epilepsy affects around a quarter of adults with intellectual disability (ID), a group 
numbering nearly one million in England (McGrother et al. 2006). A study of adults with 
ID in Scotland demonstrated a point prevalence of epilepsy in that sample of 34% 
(Kinnear et al. 2018). For comparison, the pooled estimate for the point prevalence of 
epilepsy in the general population, in high income countries, is 5.49 per 1000 (CI 4.16–
7.26) (Fiest et al. 2017). Epilepsy treatment outcomes are worse and management 
costs are higher in this group, possibly reflecting both disease severity and the 
challenges of managing health conditions in people with ID (Kerr, 2011).  The 
challenges of managing epilepsy in people with ID and the need for innovative and 
holistic approaches to coordinating care were recognised in recent reports from Public 
Health England (Marriott et al. 2014) and others (Kerr et al. 2014; MENCAP 2007). 
Clinical guidelines in the UK recommend a key role for specialist epilepsy nurses in the 
management of epilepsy (Kerr et al. 2014; NICE 2012). However, nurses with specialist 
epilepsy experience are rare and consequently access is very limited (Reuber et al. 
2008). There is a lack of a robust evidence base on the cost-effectiveness of epilepsy 
nurse specialists to support the expansion of provision. Evidence to date suggests that 
epilepsy nurse specialists have limited impact on clinical outcomes for patients but may 
reduce care costs (Johnson et al. 2010; Warren et al. 1998).  
The UK Epilepsy Specialist Nurse association has published a set of guidelines to 
support the delivery of epilepsy care in people with ID - the Learning Disability Epilepsy 
Specialist Nurse Competency Framework (Doherty et al. 2013). The framework 
supports clinical practice and professional development relating to the management of 
epilepsy by nurses with a range of experience in the treatment of epilepsy in people 





epilepsy nurses. This is important as the majority of nurses already working in services 
that manage people with ID and epilepsy are not epilepsy specialist nurses. 
The framework was evaluated in (name removed for blind review), a cluster 
randomised controlled trial across 17 centres in the UK. The trial protocol (citation 
removed for blind review) and full trial report (citation removed for blind review) have 
been previously reported. In this paper we report the impact of the competency 
framework on the cost of caring for people with epilepsy and ID. Effectiveness and 
cost-effectiveness of the framework will be reported in a later publication. 
Methods  
Study design and participant recruitment 
(Name removed for blinded review) was implemented as a cluster randomised trial to 
reflect the likelihood that nurses within a community team were likely to share duties 
and to influence each other’s practice, and the practical difficulty in delivering 
‘treatment as usual’ after having received specialist training. Sites were randomised to 
treatment or control in blocks of two or more and after participant recruitment. Whilst 
nurses could not be blinded to treatment allocation, people with epilepsy and their 
carers were not explicitly informed. Outcome and cost data were collected by research 
assistants blinded to treatment allocation. Initial plans to recruit 32 participants at each 
of 12 sites were modified to 20 participants at each of 16 sites after recruitment 
challenges. All participants were recruited from secondary care adult community ID 
teams located in both inner city and more rural areas in England, Scotland and Wales. 
The trial was powered on the primary outcome, which was the Epilepsy and Learning 
Difficulties Quality of Life (ELDQoL) (Buck et al. 2007) seizure severity subscale, 





one sided significance level of 0.025. Participants were eligible for recruitment if they 
were aged 18-65, IQ of 70 or less, a diagnosis of epilepsy with at least one seizure in 
the previous six months, and had care input from a nurse in the Community Intellectual 
Disability Team. Participants with a rapidly progressing physical or mental illness, and 
those with drug or alcohol dependence were excluded. 
Consent was obtained in face to face interviews with the participant, or where the 
potential participant lacked capacity to consent, assent was obtained from the primary 
carer under the provisions of the Mental Capacity Act (England and Wales 2005) or 
section 51 of the Adults with Incapacity Act (Scotland 2000). The study was approved 
by the England and Wales Research Ethics Committee and the Scotland A Research 
Ethics Committee. A detailed description of the trial implementation has been published 
(citation removed for blind review). 
Intervention 
Nurses in both arms received training of three hours’ duration focussed on the trial 
requirements and data collection. Nurses in sites assigned to the intervention arm 
received an additional three hours of training following guidelines laid out in the 
Learning Disability Epilepsy Specialist Nurse Competency Framework (Doherty et al. 
2013). The framework outlines competencies considered by the developers of the 
framework to be central to effective performance in supporting participants with 
epilepsy and ID. These competencies range across the domains of clinical diagnosis 
and management of epilepsy, assessing and managing risk, impact of daily life on 
epilepsy, evidence-based practice, multidisciplinary team working, and professional 
development. In each domain a range of competencies are described such that the 





according to their self-assessed competence level (‘novice’, ‘competent’ or ‘expert’). 
Nurses in both arms were free to practice as they judged clinically appropriate. 
Assessments and data collection 
Data from trial participants were collected by trial researchers at baseline and after six 
months, predominantly through telephone interview with the primary carer. 
Demographic data were collected at baseline, including postcode, which allowed 
assignment of the relevant Index of Multiple Deprivation (IMD) score. The IMD ranks 
localities according to measures of deprivation in multiple domains (Noble et al. 2006). 
Resource use was recorded at baseline and follow-up using a modified version of the 
Client Services Receipt Inventory which had been utilised in a previous study of the 
costs of supporting adults with epilepsy and intellectual disability (citation removed for 
blind review). The instrument reported the type of accommodation in which participants 
lived, their experience of respite care and holidays over the previous six months and 
contact with health and social care professionals related to their epilepsy over the 
previous month. Approximate contact times, the site of contact (home or clinic) and 
whether the family contributed to the cost (of social support) were recorded. Drug 
costs, investigations such as MRI scans and hospitalizations relevant to epilepsy were 
recorded. The instrument also reported the number of hours of informal care 
participants received. A copy of the questionnaire is included in the supplementary 
material. 
Structured daily diaries were used by the nurses in the study to collect data describing 
the time spent by the nurses supporting participants. The diaries were completed on a 
daily basis and logged the duration of time spent in activities supporting people with 





Unit costs for each element of resource use were sought from appropriate national 
sources in 2014/2015 GBP (Curtis & Burns, 2015). Costs were inflated to 2014/2015 
GBP where necessary using the Hospital and Community Health Services inflation 
index (Curtis & Burns, 2015). The following unit costs were obtained from Unit Costs of 
Health and Social Care 2015 (Curtis & Burns, 2015): outpatient appointment - £112; 
emergency ambulance - £231; passenger transport ambulance - £53; accommodation 
costs (classified as 4-bed house - £1,631 per week,  8-bed house - £1,284 per week; 
and supported living £906 per week); respite care - £280 per night (based on the mean 
cost for residential overnight respite care for disabled children), day care activities 
(such as adult education and social clubs) - £81 per session; hourly costs of primary 
health care providers, social workers, family support workers and home care support. 
Hourly costs of primary care providers are listed in table S1 in the supplementary 
material. A multiplier of 1.158 was applied to costs per contact hour for home visits; the 
multiplier is the ratio of NHS reference costs for home and clinic appointments with an 
occupational therapist (Department of Health & Social Care, 2015). Hourly costs were 
multiplied by 1.35 to estimate costs per patient contact hour based on costs per hour 
and patient contact hour for consultant surgeons reported in Unit costs of Health and 
Social Care 2010 (Curtis, 2010). Accident and Emergency admission costs (£103.67) 
and day hospital costs (£99.30) were derived from Unit Costs of Health and Social 
Care 2010 and inflated. 
The cost of hospital inpatient stays was estimated at £400 per day based on data from 
the Department of Health (Department of Health, 2015). Drug costs were estimated on 
the basis of dose, frequency, formulation and brand, where stated, from data in the 
British National Formulary (British National Formulary, accessed November 2016). 
Costs of tests and investigations were taken from NHS Reference costs (Department of 





data matched to typical holiday packages by a specialist provider (JollyDays). A cost of 
£5.08 per ‘meal on wheels’ was derived from published sources (Banerjee et al. 2013). 
Costs for cleaning (£12 per hour) and laundry services (£14) were derived from online 
suppliers. 
Informal care was valued at the gross market wage rate by category of employment 
(Office for National Statistics, 2016), or at the minimum wage for 2014/2015 of £6.50 
per hour for unemployed or retired carers. 
Costs for contacts with nurses were estimated according to duration costs per contact 
hour by Agenda for Change salary band (Curtis & Burns, 2015). Costs for home visits 
were multiplied by 1.158 as previously described. We did not include the costs of 
training nurses as it is unclear what proportion of such costs should be attributed to the 
support of participants over the first six months following training.  
Analysis of costs 
The cost analysis applied a health and social care perspective as recommended by 
NICE guidelines (NICE, 2013). A secondary analysis included costs falling on families, 
primarily travel and informal care but also paid social services to provide a societal 
perspective. The collection of resource use data over six months precluded the need 
for discounting. We undertook some ad hoc imputation of missing resource use data 
based on mean values for observed data where it was evident that contact with 
professionals had occurred but the duration was missing. Otherwise costs in the 
relevant category were recorded as missing when data were incomplete. Missing data 
were imputed using Multiple Imputation with Chained Equations in Stata (version 15) 
(Rubin, 2004). Predictive Mean Matching was used to replicate the distribution of 
observed data for missing data where the observed data was non-Normally distributed 





and epilepsy specific (ELDQOL) quality of life at baseline and follow-up, the level of ID 
(categorised as mild, moderate, severe or profound), sex, age, the number of Tonic-
Clonic seizures (categorised), IMD quintile, and the site mean of self-assessed 
competence (novice, competent or expert) and workload of epilepsy nurse specialists 
in the trial (calculated as the site mean of the number of people with epilepsy per 
nurse). 
The impact of the intervention on costs per participant recorded at six months was 
determined with adjustment for differences in baseline characteristics of participants 
and nurses. Each of the variables included in the imputation routine (listed above) were 
also included as covariates in the estimation of intervention costs. We did not envisage 
many participants with zero costs but we did expect the usual skewed data. The 
suitability of assuming Gaussian, Inverse Gaussian, Gamma and Poisson distributions 
for the dependent variable (cost) and an additive (linear) or multiplicative (log) link to 
the independent variables were explored through Generalised Linear Modelling 
(Blough & Ramsey, 2000). Uncertainty in the estimates of the impact of the intervention 
on costs were quantified through bootstrapping. One thousand bootstrap replicates 
were created prior to imputation of missing data using MI; treatment effects were 
estimated through regression modelling across imputed datasets for each bootstrap 
replicate with effects combined using Rubin’s rules to generate a single value for each 
bootstrap replicate (Rubin, 2004). Non-parametric 95% confidence intervals were 
determined after ranking the values generated across the bootstrap replicates. All 
statistical analysis was undertaken in Stata version 15. 
Subgroup analysis and sensitivity analysis 
We pre-specified analysis according to the subgroups mild/moderate ID and 





were large and crudely estimated. Consequently, we undertook sensitivity analysis in 
which these costs were ignored. Our primary analysis allowed adjustment for 
differences in baseline characteristics but did not account for the clustering of data in 
the bootstrap routine. We undertook a sensitivity analysis which applied a two-stage 
bootstrap routine which explicitly accounted for clustering (Ng et al. 2013). 
Unfortunately, the routine did not support adjustment for differences at baseline. After 
undertaking MI, the two-stage bootstrap was applied to each of 20 imputed datasets. 
Mean cost differences were derived through combining the bootstrapped estimate of 
mean costs across the 20 imputed datasets using Rubin’s rules (Rubin, 2004). 
Confidence intervals were estimated parametrically after deriving the overall standard 
deviation from bootstrapped standard error estimate for each imputed dataset using 
Rubin’s rules.  
Results 
Raw data 
Recruitment of sites began in September 2014 with the last site recruited a year later. 
Seventeen sites were recruited, of which eight were randomised to the competency 
framework intervention. Across the intervention sites 184 participants were recruited. 
Across the treatment as usual (TAU) sites 128 participants were recruited. A 
CONSORT diagram is available in the full report (citation removed for blind review). 
The primary reason for exclusion of participants was the lack of a seizure in the 
preceding six months (well controlled epilepsy). Table 1 compares the baseline 
characteristics of the participants and the specialist epilepsy nurses across treatment 
arms. There were notable differences in the experience level of nurses across the two 
arms; a higher proportion of nurses in the competency framework arm self-assessed 





Agenda for Change band 8. A higher proportion of participants in the TAU arm had mild 
or moderate ID, were non-White and lived with family. 
Table 2 presents the raw cost data at baseline and after six months and the proportion 
of missing data by treatment arm. Missing data at baseline amounted to 5% or less; 
missing data at follow-up was higher, but not more than 20% of the total. Formal 
accommodation costs amounted to around half the total costs falling on health and 
social care budgets, despite over a third of participants living with family. Drug costs, 
primary care costs, secondary care costs, respite care costs and costs of holidays were 
small. Social support, day care and informal care generated higher costs. Figure 1 
contrasts costs at baseline and six months for all participants (data tabulated in table 
S2, supplementary material). The largest (absolute) change is seen in accommodation 
costs which increase at six months. These are accompanied by a reduction in social 
support costs. Health and social care and societal costs at baseline and six months 
were between 5% and 11% higher for participants with severe or profound ID. 
Analysis of costs 
Health and social care costs at six months were moderately skewed (Figure S1, 
supplementary material); examination of alternative assumptions regarding the 
distribution of the data and the dependence of the covariates using Generalised Linear 
Modelling did not identify a superior alternative to linear regression. Hence linear 
regression was used to adjust for baseline imbalances. Table 3 reports the difference 
in costs per participant at six months attributable to the competency framework and the 
non-parametric 95% confidence intervals. The competency framework is associated 
with a reduction in costs from both the health and social care and the societal 





the bootstrap replicates (which capture sample uncertainty) indicate that the 
intervention is cost saving. The corresponding figure for societal costs is 93%. 
Subgroup analysis suggested greater cost reductions in participants with severe or 
profound ID. When accommodation costs were excluded the reduction in health and 
social care costs associated with the intervention arm was slightly higher, but the 
likelihood that the intervention saved costs was unchanged. After applying MI for 
missing data prior to a two-stage bootstrap the estimated reduction in health and social 
care costs associated with the intervention is increased but confidence intervals still 
include zero. 
Discussion 
This is the first study internationally that explores the costs of nurses using a 
competency framework to support people with intellectual disabilities and epilepsy. Our 
findings indicate that the competency framework is unlikely to increase costs and may 
reduce the overall costs of caring for adults with epilepsy and ID. The competency 
framework may be streamlining decision making, enabling self-assessment of 
competence to practise, developing the nurses’ scope of practice, and reducing 
duplication of care support (Halcomb et al. 2016). The trial was powered on the primary 
outcome and our data are insufficient to be certain that the competency framework 
lowered overall costs.  
Our data illustrate the high cost of supporting adults with epilepsy and ID. Costs of 
accommodation and social support dwarf medical costs. These findings are consistent 
with previous studies that highlight the high social care costs of supporting people with 
epilepsy and ID (Morgan et al. 2003; Burke et al. 1999). Published evidence on the 





Implementation of specialist epilepsy nurses have generated savings from reductions 
in emergency department admissions (Beasley, 2009; Warren et al. 1998), length of 
stay (Noble et al. 2014), or substitution of consultant led care (Johnson et al. 2010). 
Our data suggest the scope for cost savings in the provision of secondary care to this 
group is very limited. A quasi-experimental study across 14 GP practices in Bristol 
found no effect of specialist epilepsy nurses on resource use (Mills et al. 1999). None 
of the studies above addressed services specifically targeted at people with ID, and 
some excluded them (Noble et al. 2014). Our study is likely the largest of its kind with 
respect to people with epilepsy and ID, and our data suggest comorbid ID is associated 
with significant additional costs.  
The sampling frame for the trial included seventeen sites across England, Scotland and 
Wales providing generalisability of the results across the UK and given the high 
prevalence of epilepsy in ID internationally, this study is of global relevance. We 
deliberately chose to recruit participants whose epilepsy was not sufficiently controlled 
to prevent seizures. Management of care is likely to be more challenging in this group 
providing greater scope for the competency framework to improve outcomes and 
possibly also to reduce costs. Whilst the scope for cost saving may be smaller in 
people with well managed epilepsy it seems unlikely that the trial findings would be 
reversed in this group. We took reasonable steps to reduce the impact of bias. Data 
were collected over the telephone by research assistants blinded to the allocation of 
the participant, and participants themselves and their carers were not explicitly 
informed about their allocation to treatment. We collected cost data using an instrument 
adapted from a previous study. We were aware of the limitations of the instrument with 
respect to accommodation costs; detailed appraisal of these costs would have required 
a level of study of accommodations that was impractical and difficult to justify. Whilst 





in these costs. In that respect the consistency of findings in the base case and 
sensitivity analysis is encouraging. The generalizability of our findings depends on the 
extent of similarities in health care between the UK and other settings. Further research 
in different health care settings might establish the reproducibility of our findings in 
different settings, and explore the potential long-term benefits which may accrue from 
the continuing professional development element of the framework. 
Our study has some limitations. We struggled to recruit the number of participants from 
each centre that we had originally envisaged. However, we were able to offset this by 
recruiting more sites. We did not find a significant reduction in costs associated with the 
competency framework; a larger trial may have been able to show a significant 
difference. We attempted to apply the most rigorous available statistical techniques to 
the analysis of our data, included a principled approach to missing data through the 
use of Multiple Imputation and a non-parametric approach to quantifying uncertainty 
which accommodated the skewed distribution of the cost data. However, we had to 
address the impact of clustering and the impact of baseline differences in separate 
analyses. 
Conclusion  
Current clinical guidelines recommend a role for epilepsy nurse specialists, particularly 
in the management of complex epilepsy (Kerr et al. 2014; NICE 2012). However, as 
noted in the Introduction, such nurses are a rare and relatively expensive resource. But 
nurses trained in intellectual disabilities are employed in most if not all community ID 
teams in the United Kingdom. The results of the (name removed for blind review) trial 
suggest that such nurses, working to the competency framework to help manage the 
epilepsy of adults with ID, are unlikely to increase the costs of supporting people with 





enhancing the cost-effectiveness of support for adults with epilepsy and an ID, using 
the existing workforce. Our findings add to a modest but growing literature 
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Variable Category Competency 
Framework 
TAU Overall 
  N % N % N % 
Nurses        
Compet. levela Novice 0/18 0 8/50 16.0 8/68 11.8 
 Expert 7/18 38.9 10/50 20.0 17/68 25.0 
Prescriberb  5/17 29.4 1/45 2.2 6/62 9.7 
Full timec  8/14 57.1 17/24 70.8 25/38 65.8 
AfC Bandd 5 2/15 13.3 11/46 23.9 13/61 21.3 
 6 7/15 46.7 23/46 50.0 30/61 49.2 
 7 3/15 20.0 11/46 23.9 14/61 23.0 
Participants        
Male  99/184 53.8 61/128 47.7 160/312 51.3 
Non-white  15/179 8.4 25/125 20.0 40/304 13.2 
Level of IDe Mild 19/173 11.0 21/107 19.6 40/280 14.3 
 Moderate 31/173 17.9 24/107 22.4 55/280 19.6 
 Severe 101/173 58.4 53/107 49.5 154/280 55.0 
Accomm.f Group 78/177 44.1 40/122 32.8 118/299 39.5 
 Family 57/177 32.2 57/122 46.7 114/299 38.1 
 Indep. 13/177 7.3 9/122 7.4 22/299 7.4 
IMD Most 
deprived 
33/179 18.4 27/126 21.4 60/305 19.7 
Accomm. – accommodation. AfC – Agenda for Change. Compet. - competence. IMD – Index of 
Multiple Deprivation. Indep. – independent. aSelf assessed competency level according to the 
categories: novice, competent, expert. bProportion of specialist epilepsy nurses who were 
nurse prescribers. cSpecialist epilepsy nurses employed full time rather than part time. 
dAgenda for Change salary band of specialist epilepsy nurses (categories 5,6,7 and 8). eID level 
categorised as mild, moderate, severe or profound. fAccommodation categorised as Group 
home, living with family, living independently, other. 
 







 Competency Framework (n = 
184) 
TAU (n = 128) 
 baseline Follow-up baseline Follow-up 














Drugs 160 0% 174 0% 200 0% 160 0% 
Accommodation 3,853 4% 3,938 14% 2,949 5% 3,351 17% 
Respite care 176 4% 153 14% 129 5% 165 19% 
Holidays 71 4% 54 14% 70 5% 70 19% 
Primary health 181 4% 162 14% 221 5% 244 19% 
Social Care 795 4% 559 14% 859 5% 775 19% 
Day care 996 4% 1,062 14% 980 5% 1,259 19% 
Hospital visits 25 4% 54 14% 50 5% 93 19% 
Participant/ 
family costs 208 0% 224 0% 156 0% 165 0% 
Informal care 1,745 4% 1,783 14% 2,537 4% 2,652 19% 
Epilepsy nurse nc  57 0% nc  57 0% 
Total H&SSa  6,276 4% 6,247 14% 5,470 5% 6,288 19% 
Total societal 8,238 4% 8,288 14% 8,191 5% 9,142 20% 
aH&SS – Health and Social Services; nc – not collected 







 Mean 95% confidence 
intervala 
Health & social care costs (£) -357 -986 to 294 
Societal costs (£) -631 -1,473 to 181 
Health & social care costs, mild/moderate ID (£) -221 -1,209 to 732 
Health & social care costs, severe/profound ID (£) -457 -1,286 to 414 
Societal care costs, mild/moderate ID (£) -312 -1,682 to 1,002 
Societal care costs, severe/profound ID (£) -864 -1,953 to 160 
Health & social care costs excluding accommodation (£) -535 -1,057 to 238 
Health & social care costs two stage bootstrap (£) -588 -1879 to 703 
aNon-parametric interval derived from ranked bootstrap replicates with the exception of the 
confidence interval for the two-stage bootstrap which was derived from overall standard 
deviation of the bootstrapped mean costs across 20 imputed datasets. 
 


















 Unit cost (£) per 
contact hour 
Source Comments 
Contact with professionals for 
clinic visit (except where stated) 
   
General practitioner 225 UCHSS 2015  
Occupational therapist 38 UCHSS 2015 Hospital based OT 
Occupational therapist, home 
visit 
44 UCHSS 2015 Community OT 
Community psychiatric / 
community mental health nurse 
75 UCHSS 2015  
Community/district nurse 67 UCHSS 2015  
Psychiatrist 188* UCHSS 2015  
Social worker or care manager 79 UCHSS 2015  
Psychologist 70* UCHSS 2015  
Physiotherapist 38 UCHSS 2015  
Dietician 38 UCHSS 2015  
Speech and language therapist 38 UCHSS 2015  
Mental health team worker 53 UCHSS 2015  
Learning disability nurse 75 UCHSS 2015  
Epilepsy specialist nurse 75 UCHSS 2015  
chiropodist/podiatrist 49* UCHSS 2015  
Family support worker 51 UCHSS 2015  
Paramedic attendance (not taken 
to hospital) 
180 NHS Ref 
2015 
Per attendance 
*Cost per hour multiplied by 1.35 to estimate cost per contact hour 






 Costs by category of expenditure (£) 
Category Baseline Follow-up 
Drugs and dietary supplements 177 168 
Accommodation 3,484 3,703 
Respite care 157 158 
Holidays 71 60 
Primary health care 197 195 
Social support 821 645 
Day care 990 1140 
Secondary health care 36 69 
Informal care 2,070 2,127 
 
Table S2. Costs by category of expenditure at baseline and follow-up. 
 
Figure S1. Monthly health and social care costs at six month follow-up. 
